← Scroll for more →
Financial Statements — BBOT
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 54.06 | 52.66 | 373.69 | 408.74 | 0.66 | 0.96 | 30.85 | 1.79 | 1.81 | 1.84 | 0.25 |
| Short-term Investments | 171.65 | 199.62 | 51.77 | 59.54 | -- | -- | 124.78 | -- | -- | -- | -- |
| Total Current Assets | 242.38 | 266.50 | 432.40 | 476.01 | 0.88 | 1.24 | 1.95 | 2.04 | 2.08 | 2.11 | -- |
| Property, Plant & Equipment | 0.88 | 0.94 | 0.96 | 0.83 | -- | -- | 0.49 | -- | -- | -- | -- |
| Total Non-current Assets* | 134.33 | 151.14 | 15.99 | 8.78 | 196.51 | 194.44 | 162.35 | 190.29 | 187.80 | 185.42 | -- |
| Total Assets | 376.71 | 417.65 | 448.38 | 484.79 | 197.39 | 195.68 | 164.30 | 192.33 | 189.87 | 187.53 | -- |
| Accounts Payable | 6.73 | 12.09 | 1.37 | 3.65 | 2.52 | -- | 3.07 | -- | -- | -- | -- |
| Total Current Liabilities | 51.63 | 43.26 | 35.04 | 35.71 | 2.63 | 1.87 | 19.58 | 0.13 | 0.08 | 0.02 | -- |
| Total Non-current Liabilities* | 1.96 | 2.11 | 2.24 | 2.38 | 5.52 | 5.52 | (13.87) | 5.52 | 5.52 | 5.52 | -- |
| Total Liabilities | 53.59 | 45.37 | 37.28 | 38.09 | 8.15 | 7.39 | 5.71 | 5.65 | 5.60 | 5.54 | -- |
| Retained Earnings | (455.13) | (398.67) | (356.57) | (317.77) | (7.27) | (6.15) | (222.52) | (3.52) | (3.37) | (3.22) | -- |
| Total Stockholder Equity | 323.11 | 372.28 | 411.10 | 446.70 | (7.27) | (6.15) | (178.64) | (3.52) | (3.37) | (3.22) | (115.64) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Research & Development | 49.23 | 39.80 | 38.07 | 35.05 | -- | -- | 19.54 | -- | -- | -- |
| Selling, General & Admin | 10.96 | 6.38 | 6.95 | 14.13 | 1.12 | 2.42 | 0.22 | 0.15 | 0.15 | -- |
| Total Operating Expenses | 60.19 | 46.18 | 43.41 | 49.18 | -- | -- | 21.88 | -- | -- | -- |
| Operating Income | (60.19) | (46.18) | (93.09) | (49.18) | (1.12) | (2.42) | (21.88) | (0.15) | (0.15) | (0.07) |
| Pretax Income* | (56.45) | -- | (89.72) | (44.76) | 0.92 | (0.49) | (19.69) | 2.33 | -- | -- |
| Tax Provision | 0.00 | -- | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -- | -- |
| Net Income | (56.45) | (42.11) | (89.72) | (44.76) | 0.92 | (0.49) | (19.69) | 2.33 | 2.21 | 1.10 |
| Basic EPS | (705.20) | (526.11) | (0.49) | (1.03) | -- | -- | (1,075.56) | -- | -- | -- |
| Diluted EPS | (705.20) | (526.11) | 2.19 | (1.03) | -- | -- | (1,075.56) | -- | -- | -- |
← Scroll for more columns →
* Derived from reported values
Cash Flow Statement
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | (44.36) | (35.92) | (42.23) | (70.63) | (0.30) | (0.73) | (0.09) | (0.03) | (0.03) | (0.62) |
| Capital Expenditures | 0.05 | 0.02 | 0.07 | 0.53 | -- | -- | -- | -- | -- | -- |
| Free Cash Flow* | (44.41) | (35.94) | (42.31) | (71.16) | -- | -- | -- | -- | -- | -- |
| Investing Cash Flow | 45.73 | (285.41) | 7.77 | 65.56 | -- | -- | 0.00 | 0.00 | 0.00 | (184.00) |
| Financing Cash Flow | 0.04 | 0.30 | (0.59) | 383.99 | -- | -- | 0.00 | 0.00 | 0.00 | 186.46 |
← Scroll for more columns →
* Derived from reported values